A Study to Evaluate IBI112 in the Treatment of Subjects With Moderate to Severe Plaque Psoriasis
Clinical trial NCT05003531 · COMPLETED
Trial details
- NCT number
- NCT05003531
- Sponsor
- Innovent Biologics (Suzhou) Co. Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-23
- Primary completion
- 2022-03-25
- Enrollment
- 250
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.